收藏切换
Clinical research progress of epigenetic anti-cancer drug
收藏切换
Na NI1, Yiyun YUAN2, Qiurong CEN2, Lizhu YI2, Jiajun LI2, Junlong WANG2, *, Bing ZHOU3, *
World Clinical Drug | 2022, 43(7) : 831 - 838
Less
收藏切换
World Clinical Drug | 2022, 43(7): 831-838
• Topic •
Clinical research progress of epigenetic anti-cancer drug
Full
Na NI1, Yiyun YUAN2, Qiurong CEN2, Lizhu YI2, Jiajun LI2, Junlong WANG2, *, Bing ZHOU3, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
  • 3.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.004
Outline
收藏切换

As one of the branches of genetics, epigenetics can affect the occurrence and progression of tumors through DNA methylation, chromatin remodeling, histone modification, non-coding RNA regulation, genomic imprinting, gene silencing, RNA editing and other mechanisms. The research and development of new drugs targeting epigenetics has become one of the hotspots of anti-cancer drugs. This article reviews the clinical research progress of epigenetic anti-cancer drugs in different therapeutic fields, combination therapy and researches in drug resistance, to provide an evidence for the follow-up research and clinical usage of these drugs.

epigenetics  /  anti-cancer drug  /  clinical research
倪娜, 袁宜耘, 陈秋荣, 伊丽竹, 李佳君, 王俊龙, 周斌. 表观遗传学抗肿瘤药物的临床研究进展. 世界临床药物, 2022 , 43 (7) : 831 -838 . DOI: 10.13683/j.wph.2022.07.004
Na NI, Yiyun YUAN, Qiurong CEN, Lizhu YI, Jiajun LI, Junlong WANG, Bing ZHOU. Clinical research progress of epigenetic anti-cancer drug[J]. World Clinical Drug, 2022 , 43 (7) : 831 -838 . DOI: 10.13683/j.wph.2022.07.004
Year 2022 volume 43 Issue 7
11
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.004
  • Receive Date:2022-06-07
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-06-07
Affiliations
    1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
    3.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200040, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT